miami semaglutide lawsuit Ozempic Lawsuit: July 2026 Blindness and Gastroparesis Claims Drug maker sues 2 Florida

A study of more than 600,000 veterans followed for up to three years found that those who started taking a GLP-1 drug for diabetes were about 15% to 20% less likely to misuse substances ranging from alcohol to opioids

The OMMs and doses included were as follows: orlistat (360 mg), phentermine plus topiramate (15/92 mg), naltrexone plus bupropion (32/360 mg), liraglutide (3.0 mg), semaglutide (2.4 mg) and tirzepatide (1015 mg)

Additionally, there was no significant difference in operation time and bleeding complications

So that's the fiber piece

Men, however, did not see an increase in acne

Placebo for the Treatment of Type 2 Diabetes and Chronic Kidney Disease in DenmarkA Long-Term Cost-Effectiveness Analysis Based on Flow Sunday, June 22